311 related articles for article (PubMed ID: 19223625)
1. A small-molecule dengue virus entry inhibitor.
Wang QY; Patel SJ; Vangrevelinghe E; Xu HY; Rao R; Jaber D; Schul W; Gu F; Heudi O; Ma NL; Poh MK; Phong WY; Keller TH; Jacoby E; Vasudevan SG
Antimicrob Agents Chemother; 2009 May; 53(5):1823-31. PubMed ID: 19223625
[TBL] [Abstract][Full Text] [Related]
2. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.
Zhou Z; Khaliq M; Suk JE; Patkar C; Li L; Kuhn RJ; Post CB
ACS Chem Biol; 2008 Dec; 3(12):765-75. PubMed ID: 19053243
[TBL] [Abstract][Full Text] [Related]
3. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
[TBL] [Abstract][Full Text] [Related]
4. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
[TBL] [Abstract][Full Text] [Related]
6. A small molecule fusion inhibitor of dengue virus.
Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
Aarthy M; Singh SK
Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
[TBL] [Abstract][Full Text] [Related]
10. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule inhibitors of dengue-virus entry.
Schmidt AG; Lee K; Yang PL; Harrison SC
PLoS Pathog; 2012; 8(4):e1002627. PubMed ID: 22496653
[TBL] [Abstract][Full Text] [Related]
12. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
[TBL] [Abstract][Full Text] [Related]
13. Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry.
Pascual MJ; Merwaiss F; Leal E; Quintana ME; Capozzo AV; Cavasotto CN; Bollini M; Alvarez DE
Antiviral Res; 2018 Jan; 149():179-190. PubMed ID: 29031833
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate-related inhibitors of dengue virus entry.
Hidari KI; Abe T; Suzuki T
Viruses; 2013 Feb; 5(2):605-18. PubMed ID: 23389466
[TBL] [Abstract][Full Text] [Related]
15. Structure-based screening and validation of potential dengue virus inhibitors through classical and QM/MM affinity estimation.
Ahmed M; Kumar A; Hobman TC; Barakat K
J Mol Graph Model; 2019 Jul; 90():128-143. PubMed ID: 31082639
[TBL] [Abstract][Full Text] [Related]
16. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.
Yamamoto M; Ichinohe T; Watanabe A; Kobayashi A; Zhang R; Song J; Kawaguchi Y; Matsuda Z; Inoue JI
Viruses; 2020 Dec; 12(12):. PubMed ID: 33371476
[TBL] [Abstract][Full Text] [Related]
17. A novel flavanone derivative inhibits dengue virus fusion and infectivity.
Srivarangkul P; Yuttithamnon W; Suroengrit A; Pankaew S; Hengphasatporn K; Rungrotmongkol T; Phuwapraisirisan P; Ruxrungtham K; Boonyasuppayakorn S
Antiviral Res; 2018 Mar; 151():27-38. PubMed ID: 29360474
[TBL] [Abstract][Full Text] [Related]
18. Progress in the identification of dengue virus entry/fusion inhibitors.
De La Guardia C; Lleonart R
Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370
[TBL] [Abstract][Full Text] [Related]
19. How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion.
Chao LH; Jang J; Johnson A; Nguyen A; Gray NS; Yang PL; Harrison SC
Elife; 2018 Jul; 7():. PubMed ID: 29999491
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
